These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 37636567)

  • 1. Persisting Hypercalcemia and Hyperparathyroidism after Kidney Transplantation Have a Negative Impact on Graft and Patient Survival.
    Egli H; Burla N; Breuer E; Baron C; Hübel K; de Rougemont O; Seeger H; Vetter D
    Diagnostics (Basel); 2024 Jun; 14(13):. PubMed ID: 39001249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecalciferol supplementation effectively improved tertiary hyperparathyroidism, FGF23 resistance and lowered coronary calcification score: a prospective study.
    Hu SM; Bai YJ; Li YM; Tao Y; Wang XD; Lin T; Wang LL; Shi YY
    Endocr Connect; 2022 Aug; 11(8):. PubMed ID: 35904219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation.
    Alfieri C; Molinari P; Vettoretti S; Fusaro M; Bover J; Cianciolo G; Pisacreta AM; Di Naro M; Castellano G
    J Nephrol; 2024 Sep; ():. PubMed ID: 39223353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of secondary and tertiary hyperparathyroidism--surgical viewpoints].
    Klempa I
    Chirurg; 1999 Oct; 70(10):1089-101. PubMed ID: 10550338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory screening for hyperparathyroidism.
    Younes NA; Shafagoj Y; Khatib F; Ababneh M
    Clin Chim Acta; 2005 Mar; 353(1-2):1-12. PubMed ID: 15698586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study.
    Molinari P; Regalia A; Leoni A; Campise M; Cresseri D; Cicero E; Vettoretti S; Nardelli L; Brigati E; Favi E; Messa P; Castellano G; Alfieri CM
    Front Med (Lausanne); 2023; 10():1221086. PubMed ID: 37636567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperparathyroidism in a Large Cohort of Chinese Patients With Tumor-induced Osteomalacia.
    Ni X; Liu W; Zhang D; Li X; Chi Y; Feng J; Jin C; Pang Q; Gong Y; Cui L; Jiajue R; Yu W; Wu H; Huo L; Liu Y; Jin J; Zhou X; Lv W; Zhou L; Xia Y; Wang O; Li M; Xing X; Jiang Y; Xia W
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1224-1235. PubMed ID: 36334263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Persistent Hyperparathyroidism After Renal Transplantation.
    Yamamoto T; Tominaga Y; Okada M; Hiramitsu T; Tsujita M; Goto N; Narumi S; Watarai Y
    World J Surg; 2016 Mar; 40(3):600-6. PubMed ID: 26546189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent disorders of mineral metabolism after one year of kidney transplantation.
    Gomes LK; Custódio MR; Contieri FL; Riella MC; Nascimento MM
    J Bras Nefrol; 2016; 38(3):282-287. PubMed ID: 27737385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism.
    Zhu X; Shan C; Zhu Q; Song L; Zhou Y; Liu J; Zhang K
    Int J Clin Exp Med; 2014; 7(12):5445-52. PubMed ID: 25664054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation.
    Kandil E; Florman S; Alabbas H; Abdullah O; McGee J; Noureldine S; Slakey D; Zhang R
    Am J Med Sci; 2010 May; 339(5):420-4. PubMed ID: 20234299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia.
    Okada M; Tominaga Y; Sato T; Tomosugi T; Futamura K; Hiramitsu T; Ichimori T; Goto N; Narumi S; Kobayashi T; Uchida K; Watarai Y
    BMC Nephrol; 2022 Jun; 23(1):212. PubMed ID: 35710357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects.
    Molinari P; Alfieri CM; Mattinzoli D; Campise M; Cervesato A; Malvica S; Favi E; Messa P; Castellano G
    Front Med (Lausanne); 2022; 9():821884. PubMed ID: 35360722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis.
    Yamada S; Tsuruya K; Kitazono T; Nakano T
    Clin Exp Nephrol; 2022 Jul; 26(7):613-629. PubMed ID: 35353283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of renal osteodystrophy 1 year after kidney transplantation.
    Jørgensen HS; Behets G; Bammens B; Claes K; Meijers B; Naesens M; Sprangers B; Kuypers DRJ; D'Haese P; Evenepoel P
    Nephrol Dial Transplant; 2021 Nov; 36(11):2130-2139. PubMed ID: 34383929
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.